Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Zhao

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The EMBO Journal|April 30, 2013
BRCA1 is a negative modulator of the PRC2 complexLan Wang, Xianzhuo Zeng, Shuai Chen, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Epigenetic remodeling and 3D chromatin reorganization governed by NKX2-1 drive neuroendocrine prostate cancerXiaodong Lu, Viriya Keo, Irina Cheng, et al.
Cell Research|August 15, 2015
A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesisShuying Shen, Xiaocan Guo, Huan Yan, et al.
EMBO Reports|April 20, 2018
PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expressionHuan Liu, Xiaoming Dai, Xiaolei Cao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025
Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic StrategyOlena Odnokoz, Anupam Banerjee, Xin Cui, et al.
The Journal of Clinical Investigation|June 22, 2023
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growthGalina Gritsina, Ka-Wing Fong, Xiaodong Lu, et al.
JCI Insight|March 31, 2026
AURKA inhibitor VIC-1911 induces mitotic defects and functional BRCAness, sensitizing prostate cancer to PARP inhibitionGalina Gritsina, Sandip Kumar Rath, Hongshun Shi, et al.
Elife|October 25, 2017
Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanismWilliam Putzbach, Quan Q Gao, Monal Patel, et al.
Nature Genetics|July 21, 2025
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodelingXiaodong Lu, Viriya Keo, Irina Cheng, et al.
The Journal of Clinical Investigation|December 5, 2018
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionBing Song, Su-Hong Park, Jonathan C Zhao, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The EMBO Journal|April 30, 2013
BRCA1 is a negative modulator of the PRC2 complexLan Wang, Xianzhuo Zeng, Shuai Chen, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Epigenetic remodeling and 3D chromatin reorganization governed by NKX2-1 drive neuroendocrine prostate cancerXiaodong Lu, Viriya Keo, Irina Cheng, et al.
Cell Research|August 15, 2015
A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesisShuying Shen, Xiaocan Guo, Huan Yan, et al.
EMBO Reports|April 20, 2018
PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expressionHuan Liu, Xiaoming Dai, Xiaolei Cao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2025
Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic StrategyOlena Odnokoz, Anupam Banerjee, Xin Cui, et al.
The Journal of Clinical Investigation|June 22, 2023
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growthGalina Gritsina, Ka-Wing Fong, Xiaodong Lu, et al.
JCI Insight|March 31, 2026
AURKA inhibitor VIC-1911 induces mitotic defects and functional BRCAness, sensitizing prostate cancer to PARP inhibitionGalina Gritsina, Sandip Kumar Rath, Hongshun Shi, et al.
Elife|October 25, 2017
Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanismWilliam Putzbach, Quan Q Gao, Monal Patel, et al.
Nature Genetics|July 21, 2025
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodelingXiaodong Lu, Viriya Keo, Irina Cheng, et al.
The Journal of Clinical Investigation|December 5, 2018
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progressionBing Song, Su-Hong Park, Jonathan C Zhao, et al.
Pageof 4